A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

The government of Japan has approved a draft revision of a law aimed at strengthening the development of new drugs in the ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...